Evidence map›Paper›PMID 31760881›Full record

Observational studyTherapeutic advances in respiratory disease

Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study.

Marco Contoli, Paola Rogliani, Fabiano Di Marco, Fulvio Braido, Angelo G Corsico, Christian A Amici, Roberto Piro, Riccardo Sarzani, Patrizia Lessi, Carla Scognamillo and 3 more

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02689492 (SATisfaction and Adherence to COPD Treatment), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02689492 completednot on this map

SATisfaction and Adherence to COPD Treatment

TypeobservationalSponsorBoehringer IngelheimRan2015 to 2017Enrolled401ConditionsPulmonary Disease, Chronic Obstructive
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marco ContoliDepartment of Medical Sciences, University of Ferrara, Emilia-Romagna, Italy.
Paola RoglianiDepartment of Experimental Medicine, University of Rome 'Tor Vergata,' Rome, Italy.
Fabiano Di MarcoDepartment of Health Science, Università di Milano, Bergamo, Italy.
Fulvio BraidoDepartment of Internal Medicine, University of Genoa, Genoa, Italy.
Angelo G CorsicoDivision of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Christian A AmiciMedineos Observational Research, Modena, Emilia-Romagna, Italy.
Roberto PiroAzienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Italy.
Riccardo SarzaniInternal Medicine and Geriatrics, Università Politecnica delle Marche and IRCCS-INRCA, Ancona, Italy.
Patrizia LessiBoehringer Ingelheim Milano, Italy.
Carla ScognamilloBoehringer Ingelheim Milano, Italy.ORCID 0000-0001-8724-374X
Nicola ScichiloneDIBIMIS, University of Palermo, Palermo, Italy.
Pierachille SantusDepartment of Biomedical and Clinical Sciences (DIBIC), Università di Milano, Division of Respiratory Diseases, 'L. Sacco' Hospital, Via G.B. Grassi 74, Milan 20157, Italy.
SAT Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding the level of patients' satisfaction with treatment and its determinants have the potential to impact therapeutic management and clinical outcome in chronic conditions such as chronic obstructive pulmonary disease (COPD).

methodsA national, multicenter, longitudinal, observational study of COPD from 20 Italian pulmonary centers to explore patients' satisfaction to treatment [assessed by the Treatment Satisfaction Questionnaire, 9 items (TSQM-9)] and association with clinical parameters [including dyspnea score, COPD Assessment Test (CAT) score, exacerbation rate], adherence to treatment [Morisky Medication-Taking Adherence Scale (MMAS-4)], illness perception [evaluated by Brief Illness Perception Questionnaire (B-IPQ)] in a 1-year follow up.

resultsA total of 401 COPD patients were enrolled [69.4% group B Global Initiative for COPD (GOLD), considering 366 patients with available GOLD 2017 classification at enrollment]. At enrollment, satisfaction with treatment was moderate, being TSQM-9 mean scores for effectiveness 64.2 [95% confidence interval (CI) 62.5-65.9], for convenience 75.8 (95% CI 74.2-77.3), and for global satisfaction 65.7 (95% CI 64.0-67.4). Global satisfaction was negatively associated with disease perception (β = -0.4709,

conclusionsThe results of this real-life study showed that the patients' satisfaction with treatments is only moderate in COPD. A high grade of patients' satisfaction is associated mainly with a low perception of the disease, high adherence to treatment and lower level of dyspnea.

trial registrationClinicaltrials.gov identifier: NCT02689492

Indexed as

Drug MonitoringAdministration, InhalationAgedDyspneaFemaleFollow-Up StudiesHumansItalyMaleMiddle AgedPatient SatisfactionPulmonary Disease, Chronic ObstructiveSurveys and QuestionnairesadherenceCOPDtreatment satisfaction

Identifiers

PMID31760881
PMCPMC6878607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.